The US media said that the Biden administration is considering imposing new sanctions on Russian oil trade. Informed sources: The details have yet to be finalized. The Bloomberg website reported on the 10th local time that the Biden administration is considering imposing new sanctions on Russian oil trade before Trump returns to the White House, and the specific details have yet to be finalized. The article said that the Biden administration is weighing new and stricter sanctions against Russia's lucrative oil trade, trying to increase pressure on the Kremlin before Trump returns to the White House. According to an insider who asked not to be named, the details of possible new measures are still being worked out, but Biden's team is considering imposing restrictions on some Russian oil exports. Up to now, the Russian side has not responded. (CCTV)Turkish Defense Ministry source: Syrian allies continue to advance in northern Syria to "eliminate terrorism".President of Hilton Asia Pacific: India's outbound travel will be the story of the next decade. According to the data of the World Tourism and Travel Council, in 2023, Indian tourists spent $34.2 billion on outbound travel. Allen Watts, president of Hilton Asia Pacific, said that compared with the future, the current level of Indian outbound travel consumption is "negligible". "The story of India is unfolding before us," he said. "India's outbound travel will be the story of the next decade." According to the World Tourism and Travel Council's Economic Impact in 2024 report, by 2034, the outbound spending of Indian tourists is expected to more than double, reaching 76.8 billion US dollars, which will make India's position in the global tourism consumption country rise from the 12th in 2023 to the 7th.
The monkeypox vaccine with independent intellectual property rights in China was approved for clinical use. On December 10th, the monkeypox vaccine jointly developed by China Bio-Beijing Institute of Biological Products and China Center for Disease Control and Prevention received the approval notice of drug clinical trial issued by National Medical Products Administration, and it was registered and classified as Class 1.2 innovative vaccine. The vaccine is an innovative vaccine independently developed by scientists in China with completely independent intellectual property rights, which is expected to play an important role in the prevention and control of diseases caused by monkeypox virus in China. (China Biology)The Nikkei 225 index just broke through the 39,900.00 mark, and the latest report was 39,899.07, up 1.34% in the day.Dagang shares: the bankruptcy proceedings of China University of Science and Technology Port have ended, and Dagang shares announced that the bankruptcy proceedings of Jiangsu University of Science and Technology Port Laser Technology Co., Ltd., a holding subsidiary of the company, have ended. Since the bankruptcy administrator took over the port of China University of Science and Technology, it is no longer included in the scope of the company's consolidated statements.
US natural gas futures rose 6% in the day, and US natural gas futures rose 6% in the day, and are now reported at $3.353 per million British heat.Zhu Min, former vice president of IMF: Domestic consumption, manufacturing and green transformation will become the growth drivers of China's economy. Recently, at the China 2024 Annual Meeting and the 22nd Financial Billboard, Zhu Min, former vice president of China International Economic Exchange Center, said that one of the three traditional locomotives of China's economic growth is infrastructure investment; The second is the real estate industry, and the third is export. The transformation of the whole economic structure needs a new growth impetus. Zhu Min said that this new growth driver is, first, based on domestic consumption, and second, insisting on doing a good job in domestic manufacturing and doing high technology; The third is green transformation. We will continue to take the road of sustainable development of green transformation in China and improve our core competitiveness.People's Insurance Company of China: In the first November, the original insurance premium income of the three subsidiaries totaled 646.933 billion yuan. From January 1, 2024 to November 30, 2024, the original insurance premium income obtained through the subsidiaries of China People's Property Insurance Co., Ltd., China People's Life Insurance Co., Ltd. and China People's Health Insurance Co., Ltd. was 496.845 billion yuan, 102.591 billion yuan and 47.497 billion yuan respectively.
Strategy guide 12-14
Strategy guide